ABVX – Abivax ADR

ABVX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

3.8

Margin Of Safety %

Put/Call OI Ratio

0.56

EPS Next Q Diff

0.45

EPS Last/This Y

2.01

EPS This/Next Y

0.79

Price

121.47

Target Price

146.67

Analyst Recom

1.41

Performance Q

1.85

Upside

-256.0%

Beta

0.86

Ticker: ABVX

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-13	ABVX	121.5	0.53	0.29	71186
2026-04-14	ABVX	125.62	0.55	0.37	72926
2026-04-15	ABVX	121.19	0.55	0.56	75742
2026-04-16	ABVX	122.39	0.56	0.25	78658
2026-04-17	ABVX	120.1	0.55	0.39	80226
2026-04-20	ABVX	114.98	0.54	0.34	64737
2026-04-21	ABVX	111.46	0.52	0.42	69397
2026-04-22	ABVX	115.98	0.52	0.15	72640
2026-04-23	ABVX	112.92	0.51	1.28	74194
2026-04-24	ABVX	114.54	0.55	0.23	76850
2026-04-27	ABVX	112.06	0.58	0.45	67568
2026-04-28	ABVX	109.89	0.59	0.22	70584
2026-04-29	ABVX	106.24	0.57	0.54	73358
2026-04-30	ABVX	117.37	0.57	0.30	75526
2026-05-01	ABVX	117.46	0.54	0.18	79926
2026-05-04	ABVX	117.21	0.56	0.62	73595
2026-05-05	ABVX	123.78	0.56	0.23	75098
2026-05-06	ABVX	126.78	0.53	0.60	81094
2026-05-07	ABVX	124.64	0.53	0.22	84894
2026-05-08	ABVX	122.68	0.52	0.43	86448
2026-05-11	ABVX	122.21	0.52	0.69	80494
2026-05-12	ABVX	121.87	0.56	1.43	84270
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-13	ABVX	121.47	-	-	-3.63
2026-04-14	ABVX	125.68	-	-	-3.63
2026-04-15	ABVX	121.27	-	-	-3.63
2026-04-16	ABVX	122.37	-	-	-3.63
2026-04-17	ABVX	120.15	-	-	-3.63
2026-04-20	ABVX	115.08	-	-	-3.63
2026-04-21	ABVX	111.53	-	-	-3.63
2026-04-22	ABVX	115.98	-	-	-3.63
2026-04-23	ABVX	112.93	-	-	-3.63
2026-04-24	ABVX	114.52	-	-	-3.63
2026-04-27	ABVX	111.94	-	-	-3.63
2026-04-28	ABVX	109.82	-	-	-3.64
2026-04-29	ABVX	106.35	-	-	-3.64
2026-04-30	ABVX	117.34	-	-	-3.64
2026-05-01	ABVX	117.47	-	-	-3.64
2026-05-04	ABVX	117.12	-	-	-3.64
2026-05-05	ABVX	123.71	-	-	-3.64
2026-05-06	ABVX	126.56	-	-	-3.64
2026-05-07	ABVX	124.66	-	-	-3.64
2026-05-08	ABVX	122.65	-	-	-3.64
2026-05-11	ABVX	122.21	-	-	-3.64
2026-05-12	ABVX	121.47	-	-	-3.64
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-13	ABVX	0.00	-8.31	4.91
2026-04-14	ABVX	0.00	-8.31	4.91
2026-04-15	ABVX	0.00	-8.31	4.91
2026-04-17	ABVX	0.00	-8.31	4.91
2026-04-20	ABVX	0.00	-8.02	4.91
2026-04-21	ABVX	0.00	-8.02	4.91
2026-04-22	ABVX	0.00	-8.02	4.90
2026-04-23	ABVX	0.00	-8.02	4.90
2026-04-24	ABVX	0.00	-8.02	4.90
2026-04-27	ABVX	0.00	-6.36	3.84
2026-04-28	ABVX	0.00	-6.36	3.84
2026-04-29	ABVX	0.00	-6.36	3.84
2026-04-30	ABVX	0.00	-6.36	3.84
2026-05-01	ABVX	0.00	-6.36	3.84
2026-05-04	ABVX	0.00	-5.76	3.84
2026-05-05	ABVX	0.00	-5.76	3.84
2026-05-06	ABVX	0.00	-5.76	3.84
2026-05-07	ABVX	0.00	-5.76	3.84
2026-05-08	ABVX	0.00	-5.76	3.84
2026-05-11	ABVX	0.00	-4.98	3.82
2026-05-12	ABVX	0.00	-4.98	3.80
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-1.19

Avg. EPS Est. Current Quarter

-0.81

Avg. EPS Est. Next Quarter

-0.74

Insider Transactions

Institutional Transactions

-4.98

Beta

0.86

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

18.4

Max Drawdown 5-Year %

Target Price

146.67

P/E

Forward P/E

PEG

P/S

P/B

17.83

P/Free Cash Flow

EPS

-5.41

Average EPS Est. Cur. Y

-3.64

EPS Next Y. (Est.)

-2.85

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.76

Return on Equity vs Sector %

-100.7

Return on Equity vs Industry %

-85.2

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

◆ ABVX Healthcare

$121.39

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

13/25

Volume

9/15

Valuation

7/20

TP/AR

2/10

Options

3/10

RSI

53.6

Range 1M

65.8%

Sup Dist

1.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

17/30

Estimates

0/20

Inst/Vol

2/15

Options

5/10

EPS Yr

27.7%

EPS NY

18.8%

52W%

80.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +20.8% upside

Quality

2/30

Valuation

6/30

Growth

12/25

Stability

6/10

LT Trend

0/5

Upside

+20.8%

Quality

Abivax SA

Sector: Healthcare

Industry: Biotechnology

Employees: 69

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

ABVX

Latest News

—

Caricamento notizie per ABVX…

stock quote shares ABVX – Abivax ADR Stock Price stock today

news today ABVX – Abivax ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch ABVX – Abivax ADR yahoo finance google finance

stock history ABVX – Abivax ADR invest stock market

stock prices ABVX premarket after hours

ticker ABVX fair value insiders trading

SNY – Sanofi

SNY — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.33

Margin Of Safety %

Put/Call OI Ratio

1.07

EPS Next Q Diff

0.55

EPS Last/This Y

1.07

EPS This/Next Y

0.37

Price

42.85

Target Price

53.92

Analyst Recom

2.29

Performance Q

-11.87

Upside

-27.5%

Beta

0.32

Ticker: SNY

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-13	SNY	46.98	1.02	0.35	56426
2026-04-14	SNY	47.63	1.02	0.33	56442
2026-04-15	SNY	48	1.01	1.27	56711
2026-04-20	SNY	47.97	1.11	0.32	49057
2026-04-23	SNY	47.56	1.11	0.11	53063
2026-04-24	SNY	46.81	1.19	0.33	51942
2026-04-27	SNY	45.91	1.20	0.98	52161
2026-04-28	SNY	45.97	1.20	0.54	52805
2026-04-29	SNY	46.04	1.20	1.10	52895
2026-04-30	SNY	46.57	1.21	0.82	54701
2026-05-01	SNY	46.1	1.21	0.06	55824
2026-05-04	SNY	43.31	1.31	1.03	55308
2026-05-05	SNY	43.39	1.24	0.14	55494
2026-05-06	SNY	43.74	1.18	0.26	56449
2026-05-07	SNY	43.19	1.15	0.11	56833
2026-05-08	SNY	43.31	1.10	0.18	57242
2026-05-11	SNY	42.5	1.08	0.51	58160
2026-05-12	SNY	42.85	1.07	0.84	58391
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-13	SNY	46.97	0.5	4303.0	4.97
2026-04-14	SNY	47.63	0.5	4616.0	4.97
2026-04-15	SNY	48.02	0.5	4485.4	4.97
2026-04-16	SNY	47.70	0.5	4314.9	4.97
2026-04-17	SNY	48.08	0.5	4478.8	4.97
2026-04-20	SNY	47.97	0.5	4298.1	4.97
2026-04-21	SNY	47.11	0.5	4200.5	4.97
2026-04-22	SNY	46.90	0.5	4285.6	4.97
2026-04-23	SNY	47.53	0.5	4462.1	4.83
2026-04-24	SNY	46.78	0.5	3970.1	4.83
2026-04-27	SNY	45.89	24.3	4476.6	4.83
2026-04-28	SNY	45.96	24.3	4648.6	4.96
2026-04-30	SNY	46.58	24.3	4892.0	4.96
2026-05-01	SNY	46.10	24.3	4576.7	4.80
2026-05-04	SNY	43.31	24.3	4294.8	4.80
2026-05-05	SNY	43.37	24.3	4778.2	4.81
2026-05-06	SNY	43.74	24.3	4865.3	4.81
2026-05-07	SNY	43.19	24.3	4348.9	4.81
2026-05-08	SNY	43.29	24.3	4498.9	4.81
2026-05-11	SNY	42.49	24.3	4438.2	4.81
2026-05-12	SNY	42.85	24.3	4507.7	4.81
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-13	SNY	0.00	-4.88	0.31
2026-04-14	SNY	0.00	-4.88	0.31
2026-04-15	SNY	0.00	-4.88	0.31
2026-04-16	SNY	0.00	-4.88	0.31
2026-04-17	SNY	0.00	-4.88	0.31
2026-04-20	SNY	0.00	-4.92	0.31
2026-04-21	SNY	0.00	-4.92	0.31
2026-04-22	SNY	0.00	-4.92	0.31
2026-04-23	SNY	0.00	-4.92	0.31
2026-04-24	SNY	0	-4.92	0.31
2026-04-27	SNY	0	-5.80	0.32
2026-04-28	SNY	0	-5.80	0.32
2026-04-29	SNY	0	-5.80	0.32
2026-04-30	SNY	0	-5.80	0.32
2026-05-01	SNY	0	-5.80	0.32
2026-05-04	SNY	0	-3.12	0.32
2026-05-05	SNY	0	-3.12	0.32
2026-05-06	SNY	0	-3.12	0.32
2026-05-07	SNY	0	-3.12	0.32
2026-05-08	SNY	0	-3.12	0.32
2026-05-11	SNY	0	-3.67	0.32
2026-05-12	SNY	0	-3.67	0.33
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

1.1

Avg. EPS Est. Current Quarter

1.13

Avg. EPS Est. Next Quarter

1.65

Insider Transactions

Institutional Transactions

-3.67

Beta

0.32

Average Sales Estimate Current Quarter

10812

Average Sales Estimate Next Quarter

13273

Fair Value

57.86

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

28.7

Max Drawdown 5-Year %

-33.5

Target Price

53.92

P/E

17.95

Forward P/E

8.06

PEG

1.11

P/S

2.08

P/B

1.23

P/Free Cash Flow

9.81

EPS

2.39

Average EPS Est. Cur. Y

4.81

EPS Next Y. (Est.)

5.19

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

11.81

Relative Volume

1.16

Return on Equity vs Sector %

-21.6

Return on Equity vs Industry %

-31.7

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.2

EBIT Estimation

4507.7

◆ SNY Healthcare

$42.86

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

23/25

Volume

1/15

Valuation

18/20

TP/AR

1/10

Options

2/10

RSI

32.7

Range 1M

6.6%

Sup Dist

1.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

14/25

Growth

9/30

Estimates

5/20

Inst/Vol

2/15

Options

3/10

EPS Yr

6.8%

EPS NY

6.6%

52W%

3.7%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +44.4% upside

Quality

14/30

Valuation

20/30

Growth

7/25

Stability

3/10

LT Trend

4/5

Upside

+44.4%

Quality

MoS

35%

Sanofi

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 74846

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

SNY

Latest News

—

Caricamento notizie per SNY…

stock quote shares SNY – Sanofi Stock Price stock today

news today SNY – Sanofi stock forecast ,stock prediction 2023 2024 2025

marketwatch SNY – Sanofi yahoo finance google finance

stock history SNY – Sanofi invest stock market

stock prices SNY premarket after hours

ticker SNY fair value insiders trading

TTE – Total Energies SE

TTE — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.21

Margin Of Safety %

Put/Call OI Ratio

0.8

EPS Next Q Diff

0.52

EPS Last/This Y

5.94

EPS This/Next Y

-1.4

Price

91.74

Target Price

97.38

Analyst Recom

2.4

Performance Q

23.01

Upside

-2.3%

Beta

0.16

Ticker: TTE

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-13	TTE	93.6	0.84	0.84	83247
2026-04-14	TTE	91.01	0.85	0.45	83843
2026-04-15	TTE	87.12	0.84	0.38	84012
2026-04-20	TTE	87.35	0.82	0.20	78174
2026-04-23	TTE	90.46	0.79	0.42	81401
2026-04-24	TTE	89.73	0.80	3.76	81809
2026-04-27	TTE	88.72	0.80	0.15	82082
2026-04-28	TTE	91.01	0.81	0.02	82073
2026-04-29	TTE	92.3	0.78	0.06	83795
2026-04-30	TTE	92.7	0.77	0.95	84601
2026-05-01	TTE	92.8	0.77	0.05	84940
2026-05-04	TTE	92.32	0.79	4.14	84060
2026-05-05	TTE	93.56	0.80	0.03	85114
2026-05-06	TTE	89.91	0.80	0.69	85336
2026-05-07	TTE	88.69	0.80	0.50	85316
2026-05-08	TTE	88.48	0.79	0.93	85065
2026-05-11	TTE	90.66	0.80	0.23	85835
2026-05-12	TTE	91.72	0.80	1.08	85962
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-13	TTE	93.42	-	-2358.5	11.16
2026-04-14	TTE	91.04	-	-3474.6	11.16
2026-04-15	TTE	87.04	-	414.0	11.16
2026-04-16	TTE	90.70	-	1544.8	11.16
2026-04-17	TTE	87.08	-	515.1	11.16
2026-04-20	TTE	87.33	-	1770.2	11.16
2026-04-21	TTE	88.32	-	776.0	10.93
2026-04-22	TTE	89.59	-	999.8	10.93
2026-04-23	TTE	90.49	-	917.8	10.93
2026-04-24	TTE	89.73	-	8370.1	10.88
2026-04-27	TTE	88.74	-	8190.5	11.11
2026-04-28	TTE	91.06	-	9509.5	11.11
2026-04-30	TTE	92.71	-	9849.5	11.11
2026-05-01	TTE	92.72	-	7234.2	11.11
2026-05-04	TTE	92.28	-	7444.7	11.13
2026-05-05	TTE	93.59	-	8113.6	12.34
2026-05-06	TTE	89.93	-	6484.2	12.34
2026-05-07	TTE	88.71	-	8047.3	12.47
2026-05-08	TTE	88.47	-	8661.2	11.68
2026-05-11	TTE	90.69	-	8110.3	11.68
2026-05-12	TTE	91.74	-	8022.1	11.78
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-13	TTE	0.00	-13.00	0.22
2026-04-14	TTE	0.00	-13.00	0.22
2026-04-15	TTE	0.00	-13.00	0.22
2026-04-16	TTE	0.00	-13.00	0.22
2026-04-17	TTE	0.00	-13.00	0.22
2026-04-20	TTE	0.00	-15.14	0.22
2026-04-21	TTE	0.00	-15.14	0.22
2026-04-22	TTE	0.00	-15.14	0.22
2026-04-23	TTE	0.00	-15.14	0.21
2026-04-24	TTE	0.00	-15.14	0.21
2026-04-27	TTE	0.00	-13.86	0.20
2026-04-28	TTE	0.00	-13.86	0.20
2026-04-29	TTE	0.00	-13.86	0.20
2026-04-30	TTE	0.00	-13.86	0.20
2026-05-01	TTE	0.00	-13.86	0.20
2026-05-04	TTE	0.00	-7.93	0.19
2026-05-05	TTE	0.00	-7.93	0.19
2026-05-06	TTE	0.00	-7.93	0.19
2026-05-07	TTE	0.00	-7.93	0.19
2026-05-08	TTE	0.00	-7.93	0.19
2026-05-11	TTE	0.00	-9.12	0.19
2026-05-12	TTE	0.00	-9.12	0.21
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

2.45

Avg. EPS Est. Current Quarter

3.18

Avg. EPS Est. Next Quarter

2.97

Insider Transactions

Institutional Transactions

-9.12

Beta

0.16

Average Sales Estimate Current Quarter

52436

Average Sales Estimate Next Quarter

50267

Fair Value

96.09

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

2.1

Max Drawdown 5-Year %

-26.3

Target Price

97.38

P/E

13.3

Forward P/E

9.52

PEG

0.83

P/S

1.11

P/B

1.6

P/Free Cash Flow

18.35

EPS

6.9

Average EPS Est. Cur. Y

11.78

EPS Next Y. (Est.)

10.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.2

Relative Volume

0.33

Return on Equity vs Sector %

2.1

Return on Equity vs Industry %

2.6

EPS 1 7Days Diff

-0.6

EPS 1 30Days Diff

0.62

EBIT Estimation

8022.1

◆ TTE Energy

$91.80

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

14/25

Volume

8/15

Valuation

10/20

TP/AR

5/10

Options

2/10

RSI

55.4

Range 1M

77.8%

Sup Dist

1.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

19/30

Estimates

10/20

Inst/Vol

4/15

Options

3/10

EPS Yr

55.9%

EPS NY

-10.3%

52W%

94.9%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟡 HOLD +26.1% upside

Quality

8/30

Valuation

13/30

Growth

15/25

Stability

3/10

LT Trend

3/5

Upside

+26.1%

Quality

MoS

TotalEnergies SE

Sector: Energy

Industry: Oil & Gas Integrated

Employees: 94847

TotalEnergies SE, an integrated energy company, produces and markets oil and biofuels, natural gas, biogas and low-carbon hydrogen, renewables, and electricity in France, the United States, Europe, Brazil, India, and internationally. The company was formerly known as TOTAL SE and changed its name to TotalEnergies SE in June 2021. TotalEnergies SE was incorporated in 1924 and is headquartered in Courbevoie, France.

TTE

Latest News

—

Caricamento notizie per TTE…

stock quote shares TTE – Total Energies SE Stock Price stock today

news today TTE – Total Energies SE stock forecast ,stock prediction 2023 2024 2025

marketwatch TTE – Total Energies SE yahoo finance google finance

stock history TTE – Total Energies SE invest stock market

stock prices TTE premarket after hours

ticker TTE fair value insiders trading

CSTM – Constellium SE

CSTM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.55

Margin Of Safety %

-8

Put/Call OI Ratio

0.87

EPS Next Q Diff

-0.48

EPS Last/This Y

1.07

EPS This/Next Y

-0.49

Price

33.31

Target Price

37.6

Analyst Recom

1.4

Performance Q

35.17

Upside

21.0%

Beta

1.55

Ticker: CSTM

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-13	CSTM	30.41	0.66	0.50	34447
2026-04-14	CSTM	30.53	0.67	1.27	34897
2026-04-15	CSTM	29.66	0.68	0.29	35216
2026-04-16	CSTM	29.65	0.67	0.73	35353
2026-04-17	CSTM	29.59	0.68	1.89	35449
2026-04-20	CSTM	30.28	0.33	12.37	25828
2026-04-21	CSTM	29.95	0.60	0.44	31231
2026-04-22	CSTM	30.8	0.60	0.13	31396
2026-04-23	CSTM	30.26	0.59	12.82	31683
2026-04-24	CSTM	31.39	0.72	0.50	34325
2026-04-27	CSTM	31.2	0.71	2.27	34550
2026-04-28	CSTM	31.08	0.82	0.15	37660
2026-04-29	CSTM	32.22	0.81	2.80	38140
2026-04-30	CSTM	31.29	0.87	0.40	39709
2026-05-01	CSTM	32.02	0.87	0.53	39969
2026-05-04	CSTM	30.84	0.87	0.91	40399
2026-05-05	CSTM	32.98	0.87	0.36	40635
2026-05-06	CSTM	33.31	0.87	0.20	40605
2026-05-07	CSTM	32.91	0.87	0.66	40719
2026-05-08	CSTM	33.89	0.87	2.04	40825
2026-05-11	CSTM	34.2	0.88	1.00	41187
2026-05-12	CSTM	33.3	0.87	0.60	41464
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-13	CSTM	30.41	71.7	-	1.72
2026-04-14	CSTM	30.53	99.1	-	1.72
2026-04-15	CSTM	29.67	99.1	-	1.72
2026-04-16	CSTM	29.64	99.1	-	1.72
2026-04-17	CSTM	29.59	99.1	-	1.72
2026-04-20	CSTM	30.29	99.1	-	1.78
2026-04-21	CSTM	29.95	99.1	-	1.78
2026-04-22	CSTM	30.77	99.1	-	1.78
2026-04-23	CSTM	30.27	99.1	-	1.78
2026-04-24	CSTM	31.39	99.1	-	1.78
2026-04-27	CSTM	31.20	99.1	-	1.78
2026-04-28	CSTM	31.09	99.1	-	1.78
2026-04-30	CSTM	31.28	99.1	-	1.78
2026-05-01	CSTM	32.00	99.1	-	1.78
2026-05-04	CSTM	30.83	843.4	-	2.95
2026-05-05	CSTM	32.97	843.4	-	2.87
2026-05-06	CSTM	33.33	843.4	-	2.87
2026-05-07	CSTM	32.85	843.4	-	2.87
2026-05-08	CSTM	33.89	843.4	-	3.02
2026-05-11	CSTM	34.19	843.4	-	3.02
2026-05-12	CSTM	33.31	843.4	-	3.02
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-14	CSTM	-1.45	-2.70	6.12
2026-04-15	CSTM	-1.45	-2.70	6.12
2026-04-16	CSTM	-1.45	-2.70	6.12
2026-04-17	CSTM	-1.45	-2.70	6.12
2026-04-20	CSTM	-1.45	-2.63	6.12
2026-04-21	CSTM	-1.45	-2.63	6.12
2026-04-22	CSTM	-1.45	-2.63	6.12
2026-04-23	CSTM	-1.45	-2.63	6.12
2026-04-24	CSTM	-1.45	-2.63	6.17
2026-04-27	CSTM	-1.34	-2.17	6.21
2026-04-28	CSTM	-1.34	-2.17	6.21
2026-04-29	CSTM	-1.34	-2.17	6.21
2026-04-30	CSTM	-1.35	-2.17	6.22
2026-05-01	CSTM	-1.34	-2.17	6.22
2026-05-04	CSTM	-1.66	-4.23	6.22
2026-05-05	CSTM	-1.95	-4.23	6.22
2026-05-06	CSTM	-1.95	-4.23	6.22
2026-05-07	CSTM	-2.16	-4.23	6.22
2026-05-08	CSTM	-2.17	-4.23	6.22
2026-05-11	CSTM	-2.17	-3.88	6.22
2026-05-12	CSTM	-2.34	-3.88	5.55
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

1.02

Avg. EPS Est. Current Quarter

0.81

Avg. EPS Est. Next Quarter

0.54

Insider Transactions

-2.34

Institutional Transactions

-3.88

Beta

1.55

Average Sales Estimate Current Quarter

2308

Average Sales Estimate Next Quarter

2251

Fair Value

30.72

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-66.3

Target Price

37.6

P/E

10.75

Forward P/E

12.18

PEG

0.38

P/S

0.51

P/B

4.05

P/Free Cash Flow

25.77

EPS

3.1

Average EPS Est. Cur. Y

3.02

EPS Next Y. (Est.)

2.53

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.87

Relative Volume

0.62

Return on Equity vs Sector %

22.7

Return on Equity vs Industry %

24.6

EPS 1 7Days Diff

1.2

EPS 1 30Days Diff

1.29

EBIT Estimation

◆ CSTM Basic Materials

$33.31

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

2/25

Volume

9/15

Valuation

9/20

TP/AR

7/10

Options

4/10

RSI

62.5

Range 1M

81.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

23/30

Estimates

11/20

Inst/Vol

4/15

Options

6/10

EPS Yr

169%

EPS NY

-17.8%

52W%

95.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -0.4% upside

Quality

13/30

Valuation

6/30

Growth

19/25

Stability

2/10

LT Trend

1/5

Upside

-0.4%

Quality

MoS

-8%

Constellium SE

Sector: Basic Materials

Industry: Aluminum

Employees: 11500

Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the aerospace, packaging, automotive, commercial transportation, general industrial, and defense end-markets. It operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry. The Packaging & Automotive Rolled Products segment produces and develops rolled aluminum products, including canstock and closure stock for the beverage and food industry, as well as foil stock for the flexible packaging market. This segment also supplies automotive body sheets, heat exchangers, and battery foil products for the automotive market. The Aerospace & Transportation segment provides aluminum products including plate, sheet, and extrusions to aerospace, space, commercial transportation, general industrial, and defense sectors. The Automotive Structures & Industry segment offers structural solutions for the automotive industry including crash management systems, body structures, side impact beams, and battery enclosure components; soft and hard alloy extrusions for automotive, transportation, and general industrial applications; and profiles for rail and general industrial applications. This segment also provides downstream technology and services, which include pre-machining, surface treatment, research and development, and technical support services. It sells its products directly or through distributors in France, Germany, the Czech Republic, the United Kingdom, Switzerland, and the United States, as well as South Korea, Japan and China. The company was incorporated in 2010 and is headquartered in Paris, France.

CSTM

Latest News

—

Caricamento notizie per CSTM…

stock quote shares CSTM – Constellium SE Stock Price stock today

news today CSTM – Constellium SE stock forecast ,stock prediction 2023 2024 2025

marketwatch CSTM – Constellium SE yahoo finance google finance

stock history CSTM – Constellium SE invest stock market

stock prices CSTM premarket after hours

ticker CSTM fair value insiders trading

ABVX – Abivax ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ABVX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

SNY – Sanofi

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SNY

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y